Liposomal and lipid-based formulations of amphotericin B

Leukemia

Volumn 10, Issue SUPPL. 2, 1996, Pages

  De Marie, S ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Amphotericin B; Antifungals; Lipid based formulation; Liposomal formulation

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; DRUG CARRIER; LIPOSOME;

ANIMAL; CHEMISTRY; HUMAN; REVIEW;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; HUMANS; LIPOSOMES;

EID: 0009884148     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Perfect JR, Lindsay MH, Drew RH. Adverse drug reactions to systemic antifungals; prevention and management. Drug Safety 1992; 7: 323-363.
2. Janknegt R, De Marie S, Bakker-Woudenberg IAJM, Crommelin DJA. Liposomal and lipid formulations of amphotericin B: clinical pharmacokinetics. Clin Pharmacokinet 1992; 23: 279-291.